Cellect Biotechnology Ltd. (APOP)
Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best
Currently, Cellect Biotechnology stock doesn't match any of these trading strategies, so our recommendation is not to buy now. This doesn't mean we expect a selloff for APOP in coming sessions, or that it may not rise higher. Simply, it doesn't match our recommended trading systems
When you are a novel trader and you own a stock with some profit, it's really difficult to decide the good moment to sell and get your profits. Like when we have to buy shares, deciding when is appropiate time to sell is not a whimsical decision, and we must follow our own trading style. When selling, as well as buying, our setups are very easy to follow but are only applicable for selling stocks in your porfolio, not for selling short Cellect Biotechnology stock
A guiding principle is that you must never keep an open trade that results in greater losses than those expected at the time of the buy. When to sell shares should always be dictated by the stop-loss (automatic or manual)
In the current situation of Cellect Biotechnology there is not any eligible sell setup, so Cellect Biotechnology stock holders with operations in profit can keep their positions
Brokerage firms and financial institutions post stock ratings based on their views of the market and the fundamental and technical situation of the analyzed stock. Unfortunately, the accuracy of these predictions is not very high, and certainly not a direct buy or sell signal
We don't have any rating posted in the last month for Cellect Biotechnology
A favorite tool of many traders are the moving averages, that easily show market momentum. A moving average is the average price of a stock over a set period of time. Moving averages are usually calculated on different periods depending on the trading timeframe 21, 50, 100 and 200 days are the most usual moving averages. Learn more about Moving Averages from sources like Wikipedia and Investopedia
Investors use support and resistance levels to find price points on a chart that tend to work as glass ceiling, containing the price of an asset to move up or down. A support level is a level where the price may stop as it falls. This means that the price is more likely to "bounce off" this level rather than break through it. However, if the price breaks down this level, it is likely to continue declining until meeting another support level. On the other hand, resistances are where the price tends to find a curb as it rises. In the same way, the price is more likely to "rebound" at this level, and if it finally breaks this level, it will climb easily until it hits the next resistance
The current resistances are:
The current supports are:
This is an indicator that was introduced in the 1980s by John Bollinger. It consists of 3 lines that are outlined superimposed on the price evolution chart:
When the price moves out of the band (above the upper line or below the lower line) it shows that the price is having a very strong trend and therefore can correct the trend to the average. At this point, the price is beyond the upper band, which should mean a short-term adjustment (at least) until it is below the band
The RSI (Relative Strength Index) is an oscillator-type indicator that track price action to reveal when the share or financial asset is oversold or overbought. Oscillator indicators, such as relative strength, are intended to indicate values in the range of 0-100. The relative strength indicator is one of the best known and most widely used indicators, and it was invented by J. Welles Wilder in 1978
The RSI broke out the oversold level of 30 on September 10 after just being in the oversold zone for a single day (what can be considered a strength sign). The RSI value yesterday was 55.5. Since then, Cellect Biotechnology price exploded a 23.88%
APOP hosted the shareholders event and released the 2nd-quarter report in mid-August.
This compares to earnings of $0.00 per share same quarter last year, so reported EPS means -. Looking at revenues, figures slightly moved compared to $0.00 same quarter 12 months ago.
APOP is hosting the earnings call. If you hold or you are considering buying APOP shares, you must be aware that the financial reporting day usually has a very high volatility, and price can soar and sink with unsually low liquidity and not respecting your buy or stop-loss orders. Have a look company's website to confirm time and details about the earnings call and the earnings report.